Zenas BioPharma, Inc.

ZBIO·NasdaqGS·Healthcare
Compare
28.46+0.08 (+0.28%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close28.38
Open29.27
Day range28.0129.80
52-week range13.5044.60
Off day high−4.50%
Off 52-week high−36.19%
Volume800.74K
Avg. volume (3M)650.65K
Market cap1.85B
EPS (TTM)-9.63
Forward P/E-6.11
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.86
Shares outstanding65.18M
Short interest28.24% of float
Earnings dateAug 13, 2026 (est.)
Analyst target47.88
Profit margin0.00%

Against its peers

Compare in full ›
ZBIO ZYME ZURA ZNTL ZLAB XNCR
Market cap 1.85B 2.22B 387.23M 172.69M 2.83B 2.60B
P/E (TTM) — — — — — —
Forward P/E -6.1 25.5 -5.9 -1.0 -10.9 -9.9
Price/book 7.3 27.5 2.2 0.9 4.2 4.0
Dividend yield — — — — — —
1-year change −7.04% +72.85% +15.52% +32.84% −11.45% +150.21%
Today +0.28% +2.69% +0.75% −1.12% +3.83% +14.33%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ZBIO news ›

From the 4Search news index, newest first.

In the news

24mentions in 30 days
19with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 24 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance